Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Oxelmark L, Lindberg A, Löfberg R, Sternby B, Eriksson A, Almer S, Befrits R, Fossum B, Karlén P, Broström O, Tysk C; SOIBD, the Swedish Organization for the study of Inflammatory Bowel Disease.

Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1320-8. doi: 10.1097/MEG.0000000000000710.

2.

From IBS to DBS: The Dysbiotic Bowel Syndrome.

Benno P, Dahlgren AL, Befrits R, Norin E, Hellström PM, Midtvedt T.

J Investig Med High Impact Case Rep. 2016 May 9;4(2):2324709616648458. doi: 10.1177/2324709616648458. eCollection 2016 Apr-Jun.

3.

[Underlying dysbiosis may be the cause of some forms of IBS. Patients were free of symptoms after the administration of microbiota].

Benno P, Befrits R, Berstad A, Dahlgren AL, Norin E, Midtvedt T.

Lakartidningen. 2015 Jun 2;112. pii: DF7I. Swedish.

4.

Is irritable bowel syndrome a dysbiotic bowel syndrome?

Benno P, Befrits R, Norin E, Berstad A, Dahlgren AL, Midtvedt T, Hellström PM.

Microb Ecol Health Dis. 2015 May 29;26:27637. doi: 10.3402/mehd.v26.27637. eCollection 2015. No abstract available.

5.

Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County.

Malmborg P, Grahnquist L, Ideström M, Lindholm J, Befrits R, Björk J, Montgomery S, Hildebrand H.

Inflamm Bowel Dis. 2015 May;21(5):1098-108. doi: 10.1097/MIB.0000000000000356.

PMID:
25844958
6.

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.

Münch A, Bohr J, Miehlke S, Benoni C, Olesen M, Öst Å, Strandberg L, Hellström PM, Hertervig E, Armerding P, Stehlik J, Lindberg G, Björk J, Lapidus A, Löfberg R, Bonderup O, Avnström S, Rössle M, Dilger K, Mueller R, Greinwald R, Tysk C, Ström M; BUC-63 investigators.

Gut. 2016 Jan;65(1):47-56. doi: 10.1136/gutjnl-2014-308363. Epub 2014 Nov 25.

7.

Fabry disease simulating Crohn's ileitis.

Rubio CA, Villnow E, Sundelin B, Eriksson E, Dolapcsiev K, Björk J, Befrits R, Tengvar M, Iversen H.

Anticancer Res. 2014 May;34(5):2437-41.

PMID:
24778057
8.

Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.

Kuznetsov NV, Zargari A, Gielen AW, von Stein OD, Musch E, Befrits R, Lofberg R, von Stein P.

BMC Gastroenterol. 2014 Apr 23;14:79. doi: 10.1186/1471-230X-14-79.

9.

Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment.

Marits P, Landucci L, Sundin U, Davidsdottir L, Nilsson J, Befrits R, Wikström AC, Eberhardson M.

J Crohns Colitis. 2014 Aug;8(8):881-9. doi: 10.1016/j.crohns.2014.01.009. Epub 2014 Jan 31.

PMID:
24486178
10.

Naïve T cells in the gut: how to really find them?

Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M.

Scand J Gastroenterol. 2014 Apr;49(4):518. doi: 10.3109/00365521.2014.884159. Epub 2014 Feb 3. No abstract available.

PMID:
24484322
11.

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.

Karlsson M, Linton L, Lampinen M, Karlén P, Glise H, Befrits R, Janczewska I, Carlson M, Winqvist O, Eberhardson M.

Scand J Gastroenterol. 2014 Jan;49(1):66-74. doi: 10.3109/00365521.2013.853829. Epub 2013 Nov 5.

PMID:
24188321
12.

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

Stein J, Bager P, Befrits R, Gasche C, Gudehus M, Lerebours E, Magro F, Mearin F, Mitchell D, Oldenburg B, Danese S.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63. doi: 10.1097/MEG.0b013e328365ca7f.

PMID:
24100539
13.

High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study.

Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF.

Scand J Gastroenterol. 2013 Nov;48(11):1286-93. doi: 10.3109/00365521.2013.838605. Epub 2013 Sep 30.

PMID:
24073709
14.

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.

Befrits R, Wikman O, Blomquist L, Hjortswang H, Hammarlund P, Bajor A, Klintman D, Blom H.

Scand J Gastroenterol. 2013 Sep;48(9):1027-32. doi: 10.3109/00365521.2013.819442. Epub 2013 Jul 29.

PMID:
23889159
15.

Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis.

Tanaka K, Rubio CA, Dlugosz A, Truskaite K, Befrits R, Lindberg G, Schmidt PT.

Gastrointest Endosc. 2013 Oct;78(4):659-64. doi: 10.1016/j.gie.2013.05.025. Epub 2013 Jul 1. No abstract available.

PMID:
23827349
16.

Carcinoma in gut-associated lymphoid tissue in ulcerative colitis: Case report and review of literature.

Rubio CA, Befrits R, Ericsson J.

World J Gastrointest Endosc. 2013 Jun 16;5(6):293-6. doi: 10.4253/wjge.v5.i6.293.

17.

Traditional serrated adenoma in a patient with Barrett's esophagus.

Rubio CA, Tanaka K, Befrits R.

Anticancer Res. 2013 Apr;33(4):1743-5.

PMID:
23564826
18.

HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD.

Linton L, Karlsson M, Grundström J, Hjalmarsson E, Lindberg A, Lindh E, Glise H, Befrits R, Janczewska I, Karlén P, Winqvist O, Eberhardson M.

Clin Transl Gastroenterol. 2012 Dec 20;3:e29. doi: 10.1038/ctg.2012.23.

19.

Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.

Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C; FERGI Study Group.

Clin Gastroenterol Hepatol. 2013 Mar;11(3):269-77. doi: 10.1016/j.cgh.2012.10.013. Epub 2012 Oct 16.

PMID:
23078888
20.

Supplemental Content

Loading ...
Support Center